Leptomeningeal metastases from solid tumours-Reference-Cited by-同舟云学术

Leptomeningeal metastases from solid tumours

Published:2021-03-16 Issue:2 Volume:14 Page:192-197
ISSN:1865-5041
Container-title:memo - Magazine of European Medical Oncology
language:en
Short-container-title:memo

Author:

Hofer Silvia^ORCID,Le Rhun Emilie

Abstract

SummaryLeptomeningeal metastases from solid tumours are increasingly being diagnosed and require a careful assessment by an interdisciplinary neuro-oncological tumour board for adequate diagnosis, therapy planning and optimal care of the affected patients.

Funder

Universität Zürich

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12254-021-00693-6.pdf

Reference33 articles.

1. Abouharb S, et al. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res Treat. 2014;146:477–86.

2. LeRhun E, et al. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology. 2020; https://doi.org/10.1093/neuonc/noaa298.

3. LeRhun E, et al. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017;28(Supplement 4):iv84–iv99.

4. Cagney DN, et al. Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases. JAMA Oncol. 2019;5(5):703–9.

5. Pardridge WM. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 2016;13(7):963–75. https://doi.org/10.1517/17425247.2016.1171315.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytopathologie du liquide céphalorachidien (LCR) ou liquide cérébrospinal (LCS);Revue Francophone des Laboratoires;2023-07

2. Neuro-oncology 2021;memo - Magazine of European Medical Oncology;2021-06